Surgical management of chondrosarcomas of the skull-base and temporal bone
European Archives of Oto-Rhino-Laryngology · 2024
DOI: 10.1007/s00405-024-08864-x ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Yi Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Chondrosarcoma, Skull Base Neoplasms, Temporal Bone. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: To analyze the overall long-term outcome of surgically treated skull base and temporal bone chondrosarcomas. METHODS: The medical records of patients with surgically treated skull base and temporal bone chondrosarcomas between 1983 and 2024 were thoroughly evaluated. RESULTS: Out of a total of over 5000 skull base surgeries performed at our center, only 29 patients had histopathologically confirmed chondrosarcomas of the skull base and temporal bone. The mean of patients age was 45.6, and the male-to-female ratio was 1.9:1. The most common symptoms included hearing loss (58.6%), tinnitus (41.4%), diplopia (31%), dysphonia (24.1%), dysphagia (20.7%), vertigo (10.3%), and dizziness (10.3%). The most frequent locations of lesions among the 29 patients are as follows: petroclival region (34.5%), jugular foramen (27.6%), petrous apex (17.2%), middle ear (13.8%), others (3.4%). TO, IFTA, IFTB, IFTC, POTS, and combined surgical approaches were commonly used. The rate of gross total removal and recurrence was 82.6% and 13.8% respectively. The follow-up duration of 6 patients was more than five years and less than ten years whereas ten patients had more than ten years of follow-up. CONCLUSIONS: Chondrosarcoma of the skull base and temporal bone is a very rare pathology. Due to its multiple potential sites of origin and histological specificity, it presents us with significant challenges. Gross total removal is the primary treatment for chondrosarcoma of the skull base and temporal bone. Personalized decision-making should be considered based on the following aspects: tumor, patient, and surgeon's factors. Postoperative radiation therapy is complementary to surgical treatment in grades II and III lesions to achieve long-term survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of ORL-HNS, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- ENT and Audiology Unit, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121, Ferrara, Italy.
- Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Jmingyang88@163.com.
- Department of Otology and Skull Base Surgery, Gruppo Otologico, 29121, Piacenza, Italy.
Zitieren
APA
Sun, Y., Yilala, M. H., Musumano, L. B., Yang, J., & Sanna, M. (2024). Surgical management of chondrosarcomas of the skull-base and temporal bone. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08864-x
Vancouver
Sun Y, Yilala MH, Musumano LB, Yang J, Sanna M. Surgical management of chondrosarcomas of the skull-base and temporal bone. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-024-08864-x
BibTeX
@article{Sun2024,
author = {Sun, Yi and Yilala, Melcol Hailu and Musumano, Lucia Belen and Yang, Jianming and Sanna, Mario},
title = {Surgical management of chondrosarcomas of the skull-base and temporal bone},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2024},
doi = {10.1007/s00405-024-08864-x}
}
EUVIMED